Releases in the national UK press today stated that Protelos can help reduce the need for joint replacement.
A news article on Calssic FM today (Friday 23rd of March) said this “New drug could reduce the need for expensive hip and knee replacement operations and was easy to take as a lemon flavoured effervescent drink”.
Literally within the hour, we had clients ringing us to ask how they could get hold of this, under the impression it was just like taking a supplement.
We are keen to ensure our patients receive up to date information on the types of treatment available, so we approached the French manufacturer, Servier, to find out the claims behind this news article and one of their medical representatives kindly telephoned us this afternoon to clarify.
As we suspected, this story has been sensationalised with a bias toward the drug saving the NHS millions in joint replacement surgery.
What is Protelos?
Protelos (Strontium ranelate) is a non hormonal drug widely available in the UK since November 2004, used to reduce the risk of bone fractures resulting from Osteoporosis in women.
Protelos contains a substance strontium ranelate, belonging to a group of medicines used to treat bone diseases and works by reducing bone breakdown and stimulating rebuilding of normal quality bone, therefore reducing the risk of fracture.
Why the hype?
He told us that a research paper has recently been presented at the European Congress on Osteoprosis in Bordeaux, France showing that there appeared to be “side effects” of the drug which seemed to help Osteoarthritic knee joints in post menopausal osteoporosis.
The French manufacturer, Servier, say they have not issued a press release regarding the use of Protelos for the treatment for Osteoarthritis.
He was keen to point out that Protelos is only licensed as a prescription only medication for the treatment of post menopausal osteoporosis in women. It is not intended or licensed as a treatment or preventative for Osteoarthritis.